Apollo Weighs Buying Stake In Credit Suisse’s Investment Banking Unit
Apollo Global Management (NYSE: APO) is reportedly looking to buy a stake in Credit Suisse Group Inc's (NYSE: CS) revamped investment bank.
How Warren Buffett’s Fund Manager Turned $70K Into $264M: ‘In A Perfect World, Nobody Would Know About This’
Legendary investor Warren Buffett is widely considered one of the greatest investors of all time.
Big Pharma Bristol-Myers Returns $475M IL-12 Oncology Asset To Dragonfly
Bristol-Myers Squibb & Co (NYSE:BMY) has returned the exclusive rights to Dragonfly Therapeutics‘ IL-12 oncology candidate. In 2020, BMS handed out $475 million in…
Johnson & Johnson’s Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder
Janssen, a unit of Johnson & Johnson (NYSE:JNJ), announced topline results from the proof-of-concept Phase 2 open-label UNITY trial for…
Sage Therapeutics-Biogen Partnered Depression Candidate Under Priority FDA Review, Analyst Says Its ‘Incrementally Positive’
The FDA has accepted for review a marketing application seeking approval for Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc’s (NASDAQ:BIIB) zuranolone for major depressive…
FedEx Cargo Plane And Southwest Airlines Passenger Flight In A Potential Collision Call At Texas Airport, Safety Board Investigates
FedEx Corp (NYSE: FDX) cargo plane coming to land at a Texas airport could have collided with Southwest Airlines Co's (NYSE: LUV) passenger jet was taking off using the same runway.
Barron’s Top Weekend Stock Picks: Apple, Disney, Pfizer And Tesla’s Price Cuts Are Leading To Growth
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Bulls And Bears Of The Week: Tesla, Meta, Apple, Snap And A Meme Coin Inspired By Musk’s Dog Up 200% In January
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Gilead Sciences’ Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
The FDA has approved Gilead Sciences Inc’s (NASDAQ:GILD) Trodelvy (sacituzumab govitecan-hziy) for adult patients with advanced or metastatic breast cancer. The…
Why Personalis Shares Are Trading Higher Today
Personalis Inc (NASDAQ:PSNL) and Moderna Inc (NASDAQ:MRNA) have signed a new agreement to continue using the Personalis NeXT Platform as part of upcoming…